Literature DB >> 19694749

Cerebral angioedema associated with enalapril.

Eric Decloedt, Rob Freercks, Gary Maartens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19694749      PMCID： PMC2767293          DOI： 10.1111/j.1365-2125.2009.03452.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  14 in total

1.  Incidence and characteristics of angioedema associated with enalapril.

Authors:  John B Kostis; Harold J Kim; James Rusnak; Thomas Casale; Allen Kaplan; Jonathan Corren; Elliott Levy
Journal:  Arch Intern Med       Date:  2005-07-25

2.  Neurological manifestations of angioedema. Report of two cases and review of the literature.

Authors:  T R Sunder; M J Balsam; M I Vengrow
Journal:  JAMA       Date:  1982-04-09       Impact factor: 56.272

3.  Cyclophosphamide type I hypersensitivity in systemic lupus erythematosus.

Authors:  B Y H Thong; K P Leong; J Thumboo; E T Koh; C Y Tang
Journal:  Lupus       Date:  2002       Impact factor: 2.911

4.  Neuropsychiatric systemic lupus erythematosus: correlation of brain MR imaging, CT, and SPECT.

Authors:  Marcelo R Abreu; Andréia Jakosky; Marcelo Folgerini; João Carlos T Brenol; Ricardo M Xavier; Flávio Kapczinsky
Journal:  Clin Imaging       Date:  2005 May-Jun       Impact factor: 1.605

Review 5.  ACE inhibitor-induced angioedema. Incidence, prevention and management.

Authors:  W Vleeming; J G van Amsterdam; B H Stricker; D J de Wildt
Journal:  Drug Saf       Date:  1998-03       Impact factor: 5.606

6.  Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations.

Authors:  M G Sabbadini; A A Manfredi; E Bozzolo; L Ferrario; C Rugarli; R Scorza; L Origgi; M Vanoli; O Gambini; L Vanzulli; D Croce; A Campana; C Messa; F Fazio; A Tincani; G Anzola; R Cattaneo; A Padovani; R Gasparotti; R Gerli; R Quartesan; M Piccirilli; A Farsi; E Emmi; A Passaleva
Journal:  Lupus       Date:  1999       Impact factor: 2.911

7.  The captopril-induced eruption. A possible mechanism: cutaneous kinin potentiation.

Authors:  J K Wilkin; J J Hammond; W M Kirkendall
Journal:  Arch Dermatol       Date:  1980-08

8.  Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors.

Authors:  Donald R Miller; Susan A Oliveria; Dan R Berlowitz; Benjamin G Fincke; Paul Stang; David E Lillienfeld
Journal:  Hypertension       Date:  2008-04-14       Impact factor: 10.190

9.  Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema.

Authors:  N J Brown; W A Ray; M Snowden; M R Griffin
Journal:  Clin Pharmacol Ther       Date:  1996-07       Impact factor: 6.875

10.  Incidence and predictors of angioedema in elderly hypertensive patients at high risk for cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors:  Linda B Piller; Charles E Ford; Barry R Davis; Chuke Nwachuku; Henry R Black; Suzanne Oparil; Tamrat M Retta; Jeffrey L Probstfield
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-09       Impact factor: 3.738
View more
  3 in total

1.  Communicating about potential drug harms: safety implications for patients.

Authors:  J M Ritter
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335

2.  Delayed presentation of ACE inhibitor-induced angio-oedema.

Authors:  Guy Amey; Pasan Waidyasekara; Ramanathan Kollengode
Journal:  BMJ Case Rep       Date:  2013-07-29

3.  Radiologic manifestations of angioedema.

Authors:  Kousei Ishigami; Sarah L Averill; Janet H Pollard; Joshua M McDonald; Yutaka Sato
Journal:  Insights Imaging       Date:  2014-05-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.